ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,331, issued on April 7, was assigned to Novartis AG (Basel, Switzerland). "Methods of treating psoriasis with secukinumab" was invented by ... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,332, issued on April 7, was assigned to Novartis AG (Basel, Switzerland). "Methods of treating psoriasis with secukinumab" was invented by ... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,333, issued on April 7, was assigned to Novartis AG (Basel, Switzerland). "Methods of treating inflammatory arthritis using IL-17 antagonis... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,334, issued on April 7, was assigned to Gmax Biopharm LLC (Hangzhou, China). "ET a R antibody, and pharmaceutical compositions and use ther... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,335, issued on April 7, was assigned to SOOCHOW UNIVERSITY (Suzhou, China). "Platinum-based drug-/photosensitizer-loaded protein nanopartic... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,336, issued on April 7, was assigned to Warburton Technology Ltd. (Dublin). "Trace element solution" was invented by William Alfred Smith (... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,337, issued on April 7, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Human serum albumin in formulations" was invente... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,338, issued on April 7, was assigned to King Faisal Specialist Hospital & Research Centre (Riyadh, Saudi Arabia). "Cisplatin analogue with ... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,339, issued on April 7, was assigned to Seaport Therapeutics Inc. (Seaport Boston, Mass.) and Monash University (Victoria, Australia). "Lip... Read More
ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,340, issued on April 7, was assigned to The Regents of the University of California (Oakland, Calif.). "Treating inflammation using LLP2A-b... Read More